Mineralocorticoid receptor antagonists (MRAs): more attention required (to prescription)!
Kardiol Pol
.
2018;76(9):1301-1302.
doi: 10.5603/KP.2018.0182.
Authors
Stefania Paolillo
1
,
Guido Carlomagno
Affiliation
1
Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. paolilloste@gmail.com.
PMID:
30211940
DOI:
10.5603/KP.2018.0182
No abstract available
Publication types
Comment
MeSH terms
Heart Failure*
Humans
Mineralocorticoid Receptor Antagonists*
Substances
Mineralocorticoid Receptor Antagonists